Zika vaccine efficacy trials could start in 2017
In the most optimistic scenario, a Zika vaccine could prove its worth by the start of 2018, Anthony Fauci, head of the U.S. National Institute of Allergy and Infectious Diseases (NIAID) in Bethesda, Maryland, said today.
Leave a Reply
Want to join the discussion?Feel free to contribute!